ATE228829T1 - Tablette mit gesteuerter freisetzung - Google Patents
Tablette mit gesteuerter freisetzungInfo
- Publication number
- ATE228829T1 ATE228829T1 AT96908487T AT96908487T ATE228829T1 AT E228829 T1 ATE228829 T1 AT E228829T1 AT 96908487 T AT96908487 T AT 96908487T AT 96908487 T AT96908487 T AT 96908487T AT E228829 T1 ATE228829 T1 AT E228829T1
- Authority
- AT
- Austria
- Prior art keywords
- controlled
- release tablet
- tablet
- release
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39579295A | 1995-02-28 | 1995-02-28 | |
PCT/US1996/002290 WO1996026718A2 (en) | 1995-02-28 | 1996-02-28 | Controlled release tablet |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE228829T1 true ATE228829T1 (de) | 2002-12-15 |
Family
ID=23564527
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96908487T ATE228829T1 (de) | 1995-02-28 | 1996-02-28 | Tablette mit gesteuerter freisetzung |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0821582B1 (de) |
JP (1) | JPH11509169A (de) |
AR (1) | AR003928A1 (de) |
AT (1) | ATE228829T1 (de) |
AU (1) | AU722741B2 (de) |
CA (1) | CA2213455A1 (de) |
DE (1) | DE69625189D1 (de) |
MY (1) | MY113429A (de) |
PA (1) | PA8388101A1 (de) |
TW (1) | TW431891B (de) |
WO (1) | WO1996026718A2 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5945125A (en) * | 1995-02-28 | 1999-08-31 | Temple University | Controlled release tablet |
WO1998029095A2 (en) * | 1997-01-03 | 1998-07-09 | Elan Corporation, Plc | Sustained release cisapride mini-tablet formulation |
US6090411A (en) * | 1998-03-09 | 2000-07-18 | Temple University | Monolithic tablet for controlled drug release |
IL150568A0 (en) | 2000-02-04 | 2003-02-12 | Depomed Inc | A controlled release oral drug dosage form |
TWI312285B (en) | 2001-10-25 | 2009-07-21 | Depomed Inc | Methods of treatment using a gastric retained gabapentin dosage |
US6723340B2 (en) * | 2001-10-25 | 2004-04-20 | Depomed, Inc. | Optimal polymer mixtures for gastric retentive tablets |
US7612112B2 (en) | 2001-10-25 | 2009-11-03 | Depomed, Inc. | Methods of treatment using a gastric retained gabapentin dosage |
NZ541008A (en) | 2003-01-13 | 2007-09-28 | Dynogen Pharmaceuticals Inc | Method of treating functional bowel disorders |
US20050013863A1 (en) | 2003-07-18 | 2005-01-20 | Depomed, Inc., A Corporation Of The State Of California | Dual drug dosage forms with improved separation of drugs |
MXPA06014587A (es) | 2004-06-17 | 2007-04-27 | Forest Laboratories | Formulaciones de liberacion modificada de formulaciones de dosificacion oral de memantina. |
BRPI0617382A2 (pt) | 2005-10-14 | 2017-07-11 | H Lundbeck As | Métodos para tratar um distúrbio do sistema nervoso central em um paciente, para tratar um paciente sofrendo de condições e uma disfunção sexual, e para reduzir um retardo na eficácia terapêutica em seguida ao início do tratamento |
US20090176882A1 (en) | 2008-12-09 | 2009-07-09 | Depomed, Inc. | Gastric retentive gabapentin dosage forms and methods for using same |
US20070202164A1 (en) * | 2006-02-28 | 2007-08-30 | Hutchison Medipharma Enterprises Limited | Andrographis Extract Formulations |
WO2010026467A2 (en) | 2008-09-04 | 2010-03-11 | Torrent Pharmaceuticals Ltd. | Controlled release dosage form of high solubility active ingredient |
EA201101524A1 (ru) | 2009-04-20 | 2012-07-30 | Элселикс Терапьютикс, Инк. | Способ и композиция для лечения состояния, связанного с хемосенсорным рецептором |
US8828953B2 (en) | 2009-04-20 | 2014-09-09 | NaZura BioHealth, Inc. | Chemosensory receptor ligand-based therapies |
US9901551B2 (en) | 2009-04-20 | 2018-02-27 | Ambra Bioscience Llc | Chemosensory receptor ligand-based therapies |
AU2011317140A1 (en) | 2010-10-19 | 2013-05-30 | Elcelyx Therapeutics, Inc. | Chemosensory receptor ligand-based therapies |
SG10201607085WA (en) | 2011-01-07 | 2016-10-28 | Elcelyx Therapeutics Inc | Chemosensory Receptor Ligand-Based Therapies |
US20130143867A1 (en) | 2011-12-02 | 2013-06-06 | Sychroneuron Inc. | Acamprosate formulations, methods of using the same, and combinations comprising the same |
WO2013158928A2 (en) | 2012-04-18 | 2013-10-24 | Elcelyx Therapeutics, Inc. | Chemosensory receptor ligand-based therapies |
JP2016520653A (ja) | 2013-06-05 | 2016-07-14 | シンクロニューロン インコーポレイテッド | アカンプロサート製剤、それを用いる方法、およびそれを含む合剤 |
US9617230B2 (en) | 2014-12-22 | 2017-04-11 | Farmington Pharma Development | Creatine prodrugs, compositions and methods of use thereof |
CA3082184A1 (en) | 2017-12-01 | 2019-06-06 | Ultragenyx Pharmaceutical Inc. | Creatine prodrugs, compositions and methods of use thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5252338A (en) * | 1991-06-27 | 1993-10-12 | Alza Corporation | Therapy delayed |
-
1996
- 1996-02-16 MY MYPI96000592A patent/MY113429A/en unknown
- 1996-02-26 AR ARP960101520A patent/AR003928A1/es unknown
- 1996-02-28 WO PCT/US1996/002290 patent/WO1996026718A2/en active IP Right Grant
- 1996-02-28 EP EP96908487A patent/EP0821582B1/de not_active Expired - Lifetime
- 1996-02-28 AT AT96908487T patent/ATE228829T1/de not_active IP Right Cessation
- 1996-02-28 CA CA002213455A patent/CA2213455A1/en not_active Abandoned
- 1996-02-28 JP JP8526317A patent/JPH11509169A/ja not_active Ceased
- 1996-02-28 AU AU51711/96A patent/AU722741B2/en not_active Ceased
- 1996-02-28 DE DE69625189T patent/DE69625189D1/de not_active Expired - Lifetime
- 1996-02-29 TW TW085102434A patent/TW431891B/zh not_active IP Right Cessation
- 1996-11-08 PA PA19968388101A patent/PA8388101A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
CA2213455A1 (en) | 1996-09-06 |
EP0821582B1 (de) | 2002-12-04 |
MY113429A (en) | 2002-02-28 |
DE69625189D1 (de) | 2003-01-16 |
AU5171196A (en) | 1996-09-18 |
EP0821582A2 (de) | 1998-02-04 |
JPH11509169A (ja) | 1999-08-17 |
WO1996026718A2 (en) | 1996-09-06 |
AR003928A1 (es) | 1998-09-30 |
AU722741B2 (en) | 2000-08-10 |
TW431891B (en) | 2001-05-01 |
WO1996026718A3 (en) | 1996-10-10 |
PA8388101A1 (es) | 1997-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE228829T1 (de) | Tablette mit gesteuerter freisetzung | |
ATE200864T1 (de) | Tablette mit gesteuerter freisetzung von alfuzosinhydrochlorid | |
DK0737738T3 (da) | Blegemiddeltablet | |
ZA96448B (en) | Tablet | |
EE04293B1 (et) | Stabiilsed lüofiliseeritud ravimvormid | |
DE69732113D1 (de) | Schnelllösliche tablette enthaltend galanthaminhydrobromid | |
DE69128569D1 (de) | Tablette mit verzögerter Wirkstoffabgabe | |
DK0966287T3 (da) | Oxacarbazepinfilmovertrukne tabletter | |
IL123614A0 (en) | Chewable tablet | |
DE59604114D1 (de) | Kautablette mit brausewirkung | |
DE69814850D1 (de) | Paracetamol enthaltende schlickbare tablette | |
BR9610214A (pt) | Compostos farmacéuticos | |
ATE300297T1 (de) | Umhüllte tablette enthaltend trimebutin maleat | |
BR9600809A (pt) | Medicamento | |
AU128017S (en) | Pharmaceutical tablet | |
FR2737885B3 (fr) | Distributeur de comprimes | |
DE69632787D1 (de) | Pharmazeutische pellets | |
DK0818964T3 (da) | Doseringsstift | |
AU129056S (en) | Pharmaceutical tablet | |
BR9610193A (pt) | 4-Tiocarbamoil-1-(2-Pirazolil)-pirazóis | |
NO965448D0 (no) | Farmasöytiske forbindelser | |
ATE240096T1 (de) | Schnellfreisetzende komprimierte flurbiprofen enthaltende tablette | |
KR970008018U (ko) | 장제용 위패 | |
UA1292S (uk) | Таблетка фармацевтична | |
SE9500250D0 (sv) | Portionstabletter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |